17-04-2024 23:17
via
medscape.com
FDA Approves Second Ustekinumab Biosimilar
The biosimilar is expected to be marketed in the United States on or after February 21, 2025.Medscape Medical News
Read more »
Nurse news
Headache, Migraine, and Antiepileptic Drugs During Pregnancy
Tapinarof Cream for Adult, Pediatric Eczema Under FDA Review
Hereditary Amyloidosis: 5 Things to Know
Optimized Hospital Care Improves Gout Treatment Uptake
Children With Chronic Skin Disorders Face Substantial Stigma
Huntington Disease: 5 Things to Know
FDA Approves New Antibiotic for Uncomplicated UTIs
Prurigo Nodularis Associated With Elevated CV Risks
British Societies Develop First 'Living' Behçet Guidelines
Blood Biomarkers Predict Knee OA Years in Advance
Don't Miss the Dx: Woman Has Unintended Weight Loss, Fatigue
FDA Seeks More Information About RDEB Rx Under Review
Starting Points if Patient Chooses Medication Abortion
What Happened to Aspirin? And What Replaces It?
Desktop versie